Bibliography
- DE CLERCQ E: Molecular targets for antiviral agents. I Pharm. Expt. Titer: (2001) 297:1–10.
- ••An excellent review on antiviral agentstargeting different viral (and mainly HIV) infections.
- DE CLERCQ E: Antiviral drugs — currentstate of the art. Clin. Vim/. (2001) 22:73–89.
- VELLA S, PALMISANO L: Antiretroviral therapy: state of the HAART Antiviral Res. (2000) 45:1–7.
- JOLY V, YENY P: New trends in antiretroviral therapy of HIV infection. Eur: J. Int. Med. (2000) 11:301–308.
- SCOZZAFAVA A, OWA T, MASTROLORENZO A, SUPURAN CT. Anticancer and antiviral sulfonamides. Carr: Med. Chem. (2003) 10:925–953.
- BALZARINI J: Effect of antimetabolite drugs of nucleotide metabolism on the anti-human immunodeficiency virus activity of nucleoside reverse transcriptase inhibitors. Pharmacol Ther (2000) 87:175–187.
- Protease Inhibitors M AIDS Therapy Ogden Rc, Flexner Cw (Eds), Marcel Dekker, New York (2001).
- SCOZZAFAVA A, MASTROLORENZO A, SUPURAN CT: Agents that target cysteine residues of biomolecules and their therapeutic potential. Exp. Opin. Ther: Patents (2001) 11:765–787.
- MASTROLORENZO A, SCOZZAFAVA A, SUPURAN CT: Small molecule antagonists of chemokine receptors as emerging anti-HIV agents. Exp. Opin. Ther. Patents (2001) 11: 1245–1252.
- VIG R, MAO C, VENKTACHALAM TK et al.: Rational design and synthesis of phenethy1-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase. Bioorg. Med. Chem. (1998) 6:1789–1797.
- ARRANZ E, DiAZ JA, INGATE ST et al: Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno [3,4- e ] [1,2,4]thiadiazines (TTDs): a new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. (1999) 7:2811–2822.
- CORBETT JW, GEARHART LA, KO SS, et al.: Novel 2, 2- dioxide -4, 4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. Lett. (2000) 10:193–195.